checkAd

     174  0 Kommentare Long-term (48-week) Data Show Treatment with Berotralstat Provides Robust and Durable Reductions in HAE Attacks and Improvements in Quality of Life Scores - Seite 3

    BCRXW

    Contact:
    John Bluth
    +1 919 859 7910
    jbluth@biocryst.com

    Lesen Sie auch

     


    Diskutieren Sie über die enthaltenen Werte


    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 3 von 3

    Verfasst von globenewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Long-term (48-week) Data Show Treatment with Berotralstat Provides Robust and Durable Reductions in HAE Attacks and Improvements in Quality of Life Scores - Seite 3 Data presented at European Academy of Allergy and Clinical Immunology (EAACI) Digital CongressRESEARCH TRIANGLE PARK, N.C., June 06, 2020 (GLOBE NEWSWIRE) - BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced new data from the APeX-2 and …